These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 12579282

  • 1. Thermoradiotherapy combined with adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.
    Higuchi Y, Asaumi J, Murakami J, Matsuzaki H, Wakasa T, Inoue T, Konoucni H, Hisatomi M, Yanagi Y, Honda Y, Shigehara H, Kishi K.
    Oncol Rep; 2003; 10(2):415-20. PubMed ID: 12579282
    [Abstract] [Full Text] [Related]

  • 2. Effects of p53 gene therapy in radiotherapy or thermotherapy of human head and neck squamous cell carcinoma cell lines.
    Higuchi Y, Asaumi J, Murakami J, Matsuzaki H, Wakasa T, Inoue T, Shigehara H, Konouchi H, Hisatomi M, Kawasaki S, Hiraki Y, Kishi K.
    Oncol Rep; 2003; 10(3):671-7. PubMed ID: 12684642
    [Abstract] [Full Text] [Related]

  • 3. Thermoradiotherapy combined with p53 gene therapy of human salivary gland adenocarcinoma cell line.
    Asaumi J, Higuchi Y, Murakami J, Matsuzaki H, Wakasa T, Inoue T, Shigehara H, Konouchi H, Hisatomi M, Kawasaki S, Kuroda M, Hiraki Y, Kishi K.
    Oncol Rep; 2003; 10(1):71-4. PubMed ID: 12469147
    [Abstract] [Full Text] [Related]

  • 4. Thermoradiotherapy in human head and neck squamous cell carcinoma cell lines.
    Asaumi J, Higuchi Y, Murakami J, Kuroda M, Shibuya K, Konouchi H, Hisatomi M, Matsuzaki H, Shigehara H, Kawasaki S, Kishi K, Hiraki Y.
    Int J Mol Med; 2002 Sep; 10(3):287-91. PubMed ID: 12165802
    [Abstract] [Full Text] [Related]

  • 5. Adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.
    Higuchi Y, Asaumi J, Murakami J, Wakasa T, Inoue T, Kuroda M, Shibuya K, Shigehara H, Kawasaki S, Fukui K, Kishi K, Hiraki Y.
    Oncol Rep; 2002 Sep; 9(6):1233-6. PubMed ID: 12375026
    [Abstract] [Full Text] [Related]

  • 6. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
    Zhang SW, Xiao SW, Liu CQ, Sun Y, Su X, Li DM, Xu G, Zhu GY, Xu B.
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):426-8. PubMed ID: 16188130
    [Abstract] [Full Text] [Related]

  • 7. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.
    Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu TJ.
    Cancer Res; 1995 Jan 01; 55(1):1-6. PubMed ID: 7805018
    [Abstract] [Full Text] [Related]

  • 8. Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neck.
    Frank DK, Frederick MJ, Liu TJ, Clayman GL.
    Clin Cancer Res; 1998 Oct 01; 4(10):2521-8. PubMed ID: 9796986
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of head and neck squamous cell carcinoma by recombinant adenovirus-p53 combined with radiotherapy: a phase II clinical trial of 42 cases].
    Zhang SW, Xiao SW, Liu CQ, Sun Y, Su X, Li DM, Xu G, Cai Y, Zhu GY, Xu B, Lü YY.
    Zhonghua Yi Xue Za Zhi; 2003 Dec 10; 83(23):2023-8. PubMed ID: 14703408
    [Abstract] [Full Text] [Related]

  • 10. p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy.
    Pirollo KF, Hao Z, Rait A, Jang YJ, Fee WE, Ryan P, Chiang Y, Chang EH.
    Oncogene; 1997 Apr 10; 14(14):1735-46. PubMed ID: 9135075
    [Abstract] [Full Text] [Related]

  • 11. Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region.
    Edelman J, Edelman J, Nemunaitis J.
    Curr Opin Mol Ther; 2003 Dec 10; 5(6):611-7. PubMed ID: 14755887
    [Abstract] [Full Text] [Related]

  • 12. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.
    Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL.
    Cancer Res; 1994 Jul 15; 54(14):3662-7. PubMed ID: 8033080
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of transfection rates on head and neck squamous cell cancer by a novel adenovirus: an in vivo and in vitro study.
    Lalonde ES, Beyer G, Friedlander PL, Kolls JK.
    Head Neck; 2002 Dec 15; 24(12):1038-46. PubMed ID: 12454941
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model.
    Eicher SA, Clayman GL, Liu TJ, Shillitoe EJ, Storthz KA, Roth JA, Lotan R.
    Clin Cancer Res; 1996 Oct 15; 2(10):1659-64. PubMed ID: 9816113
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers.
    Clayman GL, Frank DK, Bruso PA, Goepfert H.
    Clin Cancer Res; 1999 Jul 15; 5(7):1715-22. PubMed ID: 10430074
    [Abstract] [Full Text] [Related]

  • 17. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.
    Kim SH, Wong RJ, Kooby DA, Carew JF, Adusumilli PS, Patel SG, Shah JP, Fong Y.
    Eur J Cancer; 2005 Jan 15; 41(2):313-22. PubMed ID: 15661558
    [Abstract] [Full Text] [Related]

  • 18. The current status of gene therapy.
    Clayman GL.
    Semin Oncol; 2000 Aug 15; 27(4 Suppl 8):39-43. PubMed ID: 10952437
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S, Uto Y, Nagasawa H, Hori H, Nagata K, Suzuki M, Kinashi Y, Ono K.
    Anticancer Res; 2006 Aug 15; 26(2A):1261-70. PubMed ID: 16619533
    [Abstract] [Full Text] [Related]

  • 20. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL, Sinha UK.
    Head Neck; 2006 Jan 15; 28(1):15-23. PubMed ID: 16302195
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.